15-LO2 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of 15-LO2 monoclonal antibodies for research in lipid metabolism and inflammation. 15-LO2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). 15-LO2, or 15-lipoxygenase-2, plays a crucial role in the metabolism of polyunsaturated fatty acids, leading to the production of bioactive lipid mediators involved in inflammatory responses and cellular signaling. The enzyme significantly impacts cardiovascular diseases and cancer by influencing cell proliferation and apoptosis. Understanding 15-LO2 function is essential for revealing its role in various pathological conditions. Research into 15-LO2 continues to advance knowledge about lipid metabolism pathways and their effects on human health. Investigating 15-LO2 activity helps identify potential therapeutic targets for treating inflammatory disorders and cancer. Characterization of 15-LO2 expression patterns provides valuable insights into disease progression and treatment strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of lipid metabolism and its role in human health and disease.